Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-25

Clinical Trial Update: Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

View source ↗

Summary

An observational study update examining patients who started insulin therapy with Levemir or Insulatard for diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulatard (insulin isophane)
  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED